Roy Jakobs

Roy Jakobs, CEO of Royal Philips, discusses the company's significant shift from a diversified conglomerate to a focused healthcare powerhouse. He explores the challenges of millions of recalled breathing machines tied to tragic outcomes, emphasizing the importance of patient safety and trust. Jakobs also highlights how AI is reshaping medical devices, aiming to streamline healthcare delivery. The conversation dives into Philips' extensive restructuring to enhance agility and responsiveness, ensuring that innovation thrives while addressing previous controversies.

In this engaging discussion, Roy Jakobs, CEO of Royal Philips, emphasizes AI's role in enhancing patient care, while Julie Sweet of Accenture discusses its transformative impact on pharma regulations. Ryan McInerney from Visa paints a picture of future commerce enabled by AI with trusted agents, and Amin Nasser of Saudi Aramco shares insights on AI's value in energy operations. The panel highlights crucial lessons in scaling AI, urging a focus on data foundations and leadership to unlock its full potential.

Roy Jakobs, the CEO of Philips and a leader in the healthcare technology sector, discusses the company's outlook amidst challenges like declining demand in China. He emphasizes robust market growth in North America, particularly for sleep apnea solutions. Jakobs elaborates on the impact of US-China tariffs and their strategic responses, including supply chain localization and AI investments. He also shares insights into Philips’ shift in focus toward imaging and personal health, highlighting potential opportunities for re-entering key markets.